Skip to content

Penn Neurology – Division of Stroke

  • About Penn Stroke
  • News and events
  • Patient care
  • Protocols and Schedules
  • Vascular Neurology Fellowship Program
  • Phone Numbers
  • TCD MES tutorial
    • Introduction
    • Example Videos, Module 1
    • Example Videos, Module 2
  • Research
  • What we’re reading
  • Quick Takes
  • Useful links

WHAT WE’RE READING – JOURNAL CLUB

November 3, 2015July 28, 2016

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.

Share this:

  • Twitter
  • Facebook

Like this:

Like Loading...

Related

Posted in: Uncategorized, What we're reading

Post navigation

 WHAT WE’RE READING – JOURNAL CLUB
WHAT WE’RE READING – JOURNAL CLUB 

Recent Posts

  • WHAT WE’RE READING- JOURNAL CLUB
  • WHAT WE’RE READING-JOURNAL CLUB
  • WHAT WE’RE READING- JOURNAL CLUB
  • WHAT WE’RE READING- JOURNAL CLUB
  • WHAT WE’RE READING- JOURNAL CLUB
  • WHAT WE’RE READING – JOURNAL CLUB
  • WHAT WE’RE READING – JOURNAL CLUB
  • Get With The Guidelines Dinner Hosted by Dr. Steve Messe, ISC, Dallas, TX
  • Penn Stroke Reunion at the International Stroke Conference, Dallas, TX, February 2023
  • Stroke detection device developed at Penn named top 100 invention of 2022
  • WHAT WE’RE READING – JOURNAL CLUB
  • WHAT WE’RE READING – JOURNAL CLUB
  • ANA 2022 Chicago
  • Welcome to our 2022 fellows!
  • WHAT WE’RE READING – JOURNAL CLUB
Blog at WordPress.com.
  • Follow Following
    • Penn Neurology - Division of Stroke
    • Already have a WordPress.com account? Log in now.
    • Penn Neurology - Division of Stroke
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d bloggers like this: